糖尿病性黄斑浮腫の治療世界市場の発展状況と動向 2024-2030
英文タイトル: Global Diabetic Macular Edema Treatment Market Insights, Forecast to 2030
販売価格(消費税別)
個人版
マルチユーザー版
企業版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書は糖尿病性黄斑浮腫の治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは糖尿病性黄斑浮腫の治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。
世界の糖尿病性黄斑浮腫の治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは糖尿病性黄斑浮腫の治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に糖尿病性黄斑浮腫の治療市場を分類しています。本研究に含まれる主な企業は:Genentech、Novartis、GlaxoSmithKline、Eyetech Pharmaceuticals、Alimera Sciences
地域別市場区分、地域別分析は以下の通り:
アメリカとカナダ
中国
アジア
ヨーロッパ
中東、アフリカ、ラテンアメリカ
タイプ別市場セグメント:
Laser Photocoagulation Therapy
Pharmacological Therapy
Bevacizumab
Ranibizumab
Triamcinolone
用途別の市場セグメント:
Hospitals
Ophthalmic Clinics
Research Institutes
Contract Research Organizations
本レポートの詳細内容
世界の糖尿病性黄斑浮腫の治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、糖尿病性黄斑浮腫の治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の糖尿病性黄斑浮腫の治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の糖尿病性黄斑浮腫の治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、糖尿病性黄斑浮腫の治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。
糖尿病性黄斑浮腫の治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。
章の概要
第1章:糖尿病性黄斑浮腫の治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(2019~2030)
第2章:糖尿病性黄斑浮腫の治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(2019~2030)
第3章糖尿病性黄斑浮腫の治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(2019~2030)
第4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(2019~2024)
第5章:糖尿病性黄斑浮腫の治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第8章:中国の種類別、および用途別、各セグメントの収益。(2019~2030)
第9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(2019~2030)
第10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第11章:糖尿病性黄斑浮腫の治療の主要企業の概要を提供し、製品の説明と仕様、糖尿病性黄斑浮腫の治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(2019~2024)
第12章:アナリストの見解/結論
概要
Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema. Market Analysis and Insights: Global Diabetic Macular Edema Treatment Market The global Diabetic Macular Edema Treatment market is projected to grow from US$ 2937.8 million in 2024 to US$ 3327.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.1% during the forecast period. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Report Covers: This report presents an overview of global market for Diabetic Macular Edema Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of Diabetic Macular Edema Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Diabetic Macular Edema Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the Diabetic Macular Edema Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Diabetic Macular Edema Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Diabetic Macular Edema Treatment revenue, projected growth trends, production technology, application and end-user industry. Descriptive company profiles of the major global players, including Genentech, Novartis, GlaxoSmithKline, Eyetech Pharmaceuticals and Alimera Sciences, etc. Market Segmentation By Company Genentech Novartis GlaxoSmithKline Eyetech Pharmaceuticals Alimera Sciences Segment by Type Laser Photocoagulation Therapy Pharmacological Therapy Bevacizumab Ranibizumab Triamcinolone Segment by Application Hospitals Ophthalmic Clinics Research Institutes Contract Research Organizations By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Latin America, Middle East & Africa Brazil Mexico Turkey Israel GCC Countries Chapter Outline Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Revenue of Diabetic Macular Edema Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 3: Detailed analysis of Diabetic Macular Edema Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment. Chapter 7: Europe by Type, by Application and by country, revenue for each segment. Chapter 8: China by Type, and by Application, revenue for each segment. Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment. Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment. Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetic Macular Edema Treatment revenue, gross margin, and recent development, etc. Chapter 12: Analyst's Viewpoints/Conclusions
総目録
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Macular Edema Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Laser Photocoagulation Therapy
1.2.3 Pharmacological Therapy
1.2.4 Bevacizumab
1.2.5 Ranibizumab
1.2.6 Triamcinolone
1.3 Market by Application
1.3.1 Global Diabetic Macular Edema Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ophthalmic Clinics
1.3.4 Research Institutes
1.3.5 Contract Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Macular Edema Treatment Market Perspective (2019-2030)
2.2 Global Diabetic Macular Edema Treatment Growth Trends by Region
2.2.1 Diabetic Macular Edema Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Diabetic Macular Edema Treatment Historic Market Size by Region (2019-2024)
2.2.3 Diabetic Macular Edema Treatment Forecasted Market Size by Region (2025-2030)
2.3 Diabetic Macular Edema Treatment Market Dynamics
2.3.1 Diabetic Macular Edema Treatment Industry Trends
2.3.2 Diabetic Macular Edema Treatment Market Drivers
2.3.3 Diabetic Macular Edema Treatment Market Challenges
2.3.4 Diabetic Macular Edema Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Diabetic Macular Edema Treatment by Players
3.1.1 Global Diabetic Macular Edema Treatment Revenue by Players (2019-2024)
3.1.2 Global Diabetic Macular Edema Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Diabetic Macular Edema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Diabetic Macular Edema Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Diabetic Macular Edema Treatment Market Concentration Ratio
3.4.1 Global Diabetic Macular Edema Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Macular Edema Treatment Revenue in 2023
3.5 Global Key Players of Diabetic Macular Edema Treatment Head office and Area Served
3.6 Global Key Players of Diabetic Macular Edema Treatment, Product and Application
3.7 Global Key Players of Diabetic Macular Edema Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Macular Edema Treatment Breakdown Data by Type
4.1 Global Diabetic Macular Edema Treatment Historic Market Size by Type (2019-2024)
4.2 Global Diabetic Macular Edema Treatment Forecasted Market Size by Type (2025-2030)
5 Diabetic Macular Edema Treatment Breakdown Data by Application
5.1 Global Diabetic Macular Edema Treatment Historic Market Size by Application (2019-2024)
5.2 Global Diabetic Macular Edema Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Diabetic Macular Edema Treatment Market Size (2019-2030)
6.2 North America Diabetic Macular Edema Treatment Market Size by Type
6.2.1 North America Diabetic Macular Edema Treatment Market Size by Type (2019-2024)
6.2.2 North America Diabetic Macular Edema Treatment Market Size by Type (2025-2030)
6.2.3 North America Diabetic Macular Edema Treatment Market Share by Type (2019-2030)
6.3 North America Diabetic Macular Edema Treatment Market Size by Application
6.3.1 North America Diabetic Macular Edema Treatment Market Size by Application (2019-2024)
6.3.2 North America Diabetic Macular Edema Treatment Market Size by Application (2025-2030)
6.3.3 North America Diabetic Macular Edema Treatment Market Share by Application (2019-2030)
6.4 North America Diabetic Macular Edema Treatment Market Size by Country
6.4.1 North America Diabetic Macular Edema Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Diabetic Macular Edema Treatment Market Size by Country (2019-2024)
6.4.3 North America Diabetic Macular Edema Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Diabetic Macular Edema Treatment Market Size (2019-2030)
7.2 Europe Diabetic Macular Edema Treatment Market Size by Type
7.2.1 Europe Diabetic Macular Edema Treatment Market Size by Type (2019-2024)
7.2.2 Europe Diabetic Macular Edema Treatment Market Size by Type (2025-2030)
7.2.3 Europe Diabetic Macular Edema Treatment Market Share by Type (2019-2030)
7.3 Europe Diabetic Macular Edema Treatment Market Size by Application
7.3.1 Europe Diabetic Macular Edema Treatment Market Size by Application (2019-2024)
7.3.2 Europe Diabetic Macular Edema Treatment Market Size by Application (2025-2030)
7.3.3 Europe Diabetic Macular Edema Treatment Market Share by Application (2019-2030)
7.4 Europe Diabetic Macular Edema Treatment Market Size by Country
7.4.1 Europe Diabetic Macular Edema Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Diabetic Macular Edema Treatment Market Size by Country (2019-2024)
7.4.3 Europe Diabetic Macular Edema Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Diabetic Macular Edema Treatment Market Size (2019-2030)
8.2 China Diabetic Macular Edema Treatment Market Size by Type
8.2.1 China Diabetic Macular Edema Treatment Market Size by Type (2019-2024)
8.2.2 China Diabetic Macular Edema Treatment Market Size by Type (2025-2030)
8.2.3 China Diabetic Macular Edema Treatment Market Share by Type (2019-2030)
8.3 China Diabetic Macular Edema Treatment Market Size by Application
8.3.1 China Diabetic Macular Edema Treatment Market Size by Application (2019-2024)
8.3.2 China Diabetic Macular Edema Treatment Market Size by Application (2025-2030)
8.3.3 China Diabetic Macular Edema Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Diabetic Macular Edema Treatment Market Size (2019-2030)
9.2 Asia Diabetic Macular Edema Treatment Market Size by Type
9.2.1 Asia Diabetic Macular Edema Treatment Market Size by Type (2019-2024)
9.2.2 Asia Diabetic Macular Edema Treatment Market Size by Type (2025-2030)
9.2.3 Asia Diabetic Macular Edema Treatment Market Share by Type (2019-2030)
9.3 Asia Diabetic Macular Edema Treatment Market Size by Application
9.3.1 Asia Diabetic Macular Edema Treatment Market Size by Application (2019-2024)
9.3.2 Asia Diabetic Macular Edema Treatment Market Size by Application (2025-2030)
9.3.3 Asia Diabetic Macular Edema Treatment Market Share by Application (2019-2030)
9.4 Asia Diabetic Macular Edema Treatment Market Size by Region
9.4.1 Asia Diabetic Macular Edema Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Diabetic Macular Edema Treatment Market Size by Region (2019-2024)
9.4.3 Asia Diabetic Macular Edema Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Genentech
11.1.1 Genentech Company Details
11.1.2 Genentech Business Overview
11.1.3 Genentech Diabetic Macular Edema Treatment Introduction
11.1.4 Genentech Revenue in Diabetic Macular Edema Treatment Business (2019-2024)
11.1.5 Genentech Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Diabetic Macular Edema Treatment Introduction
11.2.4 Novartis Revenue in Diabetic Macular Edema Treatment Business (2019-2024)
11.2.5 Novartis Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Diabetic Macular Edema Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Diabetic Macular Edema Treatment Business (2019-2024)
11.3.5 GlaxoSmithKline Recent Developments
11.4 Eyetech Pharmaceuticals
11.4.1 Eyetech Pharmaceuticals Company Details
11.4.2 Eyetech Pharmaceuticals Business Overview
11.4.3 Eyetech Pharmaceuticals Diabetic Macular Edema Treatment Introduction
11.4.4 Eyetech Pharmaceuticals Revenue in Diabetic Macular Edema Treatment Business (2019-2024)
11.4.5 Eyetech Pharmaceuticals Recent Developments
11.5 Alimera Sciences
11.5.1 Alimera Sciences Company Details
11.5.2 Alimera Sciences Business Overview
11.5.3 Alimera Sciences Diabetic Macular Edema Treatment Introduction
11.5.4 Alimera Sciences Revenue in Diabetic Macular Edema Treatment Business (2019-2024)
11.5.5 Alimera Sciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
表と図のリスト
List of Tables Table 1. Global Diabetic Macular Edema Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030 Table 2. Key Players of Laser Photocoagulation Therapy Table 3. Key Players of Pharmacological Therapy Table 4. Key Players of Bevacizumab Table 5. Key Players of Ranibizumab Table 6. Key Players of Triamcinolone Table 7. Global Diabetic Macular Edema Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030 Table 8. Global Diabetic Macular Edema Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 9. Global Diabetic Macular Edema Treatment Market Size by Region (2019-2024) & (US$ Million) Table 10. Global Diabetic Macular Edema Treatment Market Share by Region (2019-2024) Table 11. Global Diabetic Macular Edema Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million) Table 12. Global Diabetic Macular Edema Treatment Market Share by Region (2025-2030) Table 13. Diabetic Macular Edema Treatment Market Trends Table 14. Diabetic Macular Edema Treatment Market Drivers Table 15. Diabetic Macular Edema Treatment Market Challenges Table 16. Diabetic Macular Edema Treatment Market Restraints Table 17. Global Diabetic Macular Edema Treatment Revenue by Players (2019-2024) & (US$ Million) Table 18. Global Diabetic Macular Edema Treatment Revenue Share by Players (2019-2024) Table 19. Global Top Diabetic Macular Edema Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Macular Edema Treatment as of 2023) Table 20. Global Diabetic Macular Edema Treatment Industry Ranking 2022 VS 2023 VS 2024 Table 21. Global 5 Largest Players Market Share by Diabetic Macular Edema Treatment Revenue (CR5 and HHI) & (2019-2024) Table 22. Global Key Players of Diabetic Macular Edema Treatment, Headquarters and Area Served Table 23. Global Key Players of Diabetic Macular Edema Treatment, Product and Application Table 24. Global Key Players of Diabetic Macular Edema Treatment, Product and Application Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Diabetic Macular Edema Treatment Market Size by Type (2019-2024) & (US$ Million) Table 27. Global Diabetic Macular Edema Treatment Revenue Market Share by Type (2019-2024) Table 28. Global Diabetic Macular Edema Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million) Table 29. Global Diabetic Macular Edema Treatment Revenue Market Share by Type (2025-2030) Table 30. Global Diabetic Macular Edema Treatment Market Size by Application (2019-2024) & (US$ Million) Table 31. Global Diabetic Macular Edema Treatment Revenue Share by Application (2019-2024) Table 32. Global Diabetic Macular Edema Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million) Table 33. Global Diabetic Macular Edema Treatment Revenue Share by Application (2025-2030) Table 34. North America Diabetic Macular Edema Treatment Market Size by Type (2019-2024) & (US$ Million) Table 35. North America Diabetic Macular Edema Treatment Market Size by Type (2025-2030) & (US$ Million) Table 36. North America Diabetic Macular Edema Treatment Market Size by Application (2019-2024) & (US$ Million) Table 37. North America Diabetic Macular Edema Treatment Market Size by Application (2025-2030) & (US$ Million) Table 38. North America Diabetic Macular Edema Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 39. North America Diabetic Macular Edema Treatment Market Size by Country (2019-2024) & (US$ Million) Table 40. North America Diabetic Macular Edema Treatment Market Size by Country (2025-2030) & (US$ Million) Table 41. Europe Diabetic Macular Edema Treatment Market Size by Type (2019-2024) & (US$ Million) Table 42. Europe Diabetic Macular Edema Treatment Market Size by Type (2025-2030) & (US$ Million) Table 43. Europe Diabetic Macular Edema Treatment Market Size by Application (2019-2024) & (US$ Million) Table 44. Europe Diabetic Macular Edema Treatment Market Size by Application (2025-2030) & (US$ Million) Table 45. Europe Diabetic Macular Edema Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 46. Europe Diabetic Macular Edema Treatment Market Size by Country (2019-2024) & (US$ Million) Table 47. Europe Diabetic Macular Edema Treatment Market Size by Country (2025-2030) & (US$ Million) Table 48. China Diabetic Macular Edema Treatment Market Size by Type (2019-2024) & (US$ Million) Table 49. China Diabetic Macular Edema Treatment Market Size by Type (2025-2030) & (US$ Million) Table 50. China Diabetic Macular Edema Treatment Market Size by Application (2019-2024) & (US$ Million) Table 51. China Diabetic Macular Edema Treatment Market Size by Application (2025-2030) & (US$ Million) Table 52. Asia Diabetic Macular Edema Treatment Market Size by Type (2019-2024) & (US$ Million) Table 53. Asia Diabetic Macular Edema Treatment Market Size by Type (2025-2030) & (US$ Million) Table 54. Asia Diabetic Macular Edema Treatment Market Size by Application (2019-2024) & (US$ Million) Table 55. Asia Diabetic Macular Edema Treatment Market Size by Application (2025-2030) & (US$ Million) Table 56. Asia Diabetic Macular Edema Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 57. Asia Diabetic Macular Edema Treatment Market Size by Region (2019-2024) & (US$ Million) Table 58. Asia Diabetic Macular Edema Treatment Market Size by Region (2025-2030) & (US$ Million) Table 59. Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size by Type (2019-2024) & (US$ Million) Table 60. Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size by Type (2025-2030) & (US$ Million) Table 61. Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size by Application (2019-2024) & (US$ Million) Table 62. Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size by Application (2025-2030) & (US$ Million) Table 63. Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 64. Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size by Country (2019-2024) & (US$ Million) Table 65. Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size by Country (2025-2030) & (US$ Million) Table 66. Genentech Company Details Table 67. Genentech Business Overview Table 68. Genentech Diabetic Macular Edema Treatment Product Table 69. Genentech Revenue in Diabetic Macular Edema Treatment Business (2019-2024) & (US$ Million) Table 70. Genentech Recent Developments Table 71. Novartis Company Details Table 72. Novartis Business Overview Table 73. Novartis Diabetic Macular Edema Treatment Product Table 74. Novartis Revenue in Diabetic Macular Edema Treatment Business (2019-2024) & (US$ Million) Table 75. Novartis Recent Developments Table 76. GlaxoSmithKline Company Details Table 77. GlaxoSmithKline Business Overview Table 78. GlaxoSmithKline Diabetic Macular Edema Treatment Product Table 79. GlaxoSmithKline Revenue in Diabetic Macular Edema Treatment Business (2019-2024) & (US$ Million) Table 80. GlaxoSmithKline Recent Developments Table 81. Eyetech Pharmaceuticals Company Details Table 82. Eyetech Pharmaceuticals Business Overview Table 83. Eyetech Pharmaceuticals Diabetic Macular Edema Treatment Product Table 84. Eyetech Pharmaceuticals Revenue in Diabetic Macular Edema Treatment Business (2019-2024) & (US$ Million) Table 85. Eyetech Pharmaceuticals Recent Developments Table 86. Alimera Sciences Company Details Table 87. Alimera Sciences Business Overview Table 88. Alimera Sciences Diabetic Macular Edema Treatment Product Table 89. Alimera Sciences Revenue in Diabetic Macular Edema Treatment Business (2019-2024) & (US$ Million) Table 90. Alimera Sciences Recent Developments Table 91. Research Programs/Design for This Report Table 92. Key Data Information from Secondary Sources Table 93. Key Data Information from Primary Sources List of Figures Figure 1. Global Diabetic Macular Edema Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 2. Global Diabetic Macular Edema Treatment Market Share by Type: 2023 VS 2030 Figure 3. Laser Photocoagulation Therapy Features Figure 4. Pharmacological Therapy Features Figure 5. Bevacizumab Features Figure 6. Ranibizumab Features Figure 7. Triamcinolone Features Figure 8. Global Diabetic Macular Edema Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Figure 9. Global Diabetic Macular Edema Treatment Market Share by Application: 2023 VS 2030 Figure 10. Hospitals Case Studies Figure 11. Ophthalmic Clinics Case Studies Figure 12. Research Institutes Case Studies Figure 13. Contract Research Organizations Case Studies Figure 14. Diabetic Macular Edema Treatment Report Years Considered Figure 15. Global Diabetic Macular Edema Treatment Market Size (US$ Million), Year-over-Year: 2019-2030 Figure 16. Global Diabetic Macular Edema Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 17. Global Diabetic Macular Edema Treatment Market Share by Region: 2023 VS 2030 Figure 18. Global Diabetic Macular Edema Treatment Market Share by Players in 2023 Figure 19. Global Top Diabetic Macular Edema Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Macular Edema Treatment as of 2023) Figure 20. The Top 10 and 5 Players Market Share by Diabetic Macular Edema Treatment Revenue in 2023 Figure 21. North America Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 22. North America Diabetic Macular Edema Treatment Market Share by Type (2019-2030) Figure 23. North America Diabetic Macular Edema Treatment Market Share by Application (2019-2030) Figure 24. North America Diabetic Macular Edema Treatment Market Share by Country (2019-2030) Figure 25. United States Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 26. Canada Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 27. Europe Diabetic Macular Edema Treatment Market Size YoY (2019-2030) & (US$ Million) Figure 28. Europe Diabetic Macular Edema Treatment Market Share by Type (2019-2030) Figure 29. Europe Diabetic Macular Edema Treatment Market Share by Application (2019-2030) Figure 30. Europe Diabetic Macular Edema Treatment Market Share by Country (2019-2030) Figure 31. Germany Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 32. France Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 33. U.K. Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 34. Italy Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 35. Russia Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 36. Nordic Countries Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 37. China Diabetic Macular Edema Treatment Market Size YoY (2019-2030) & (US$ Million) Figure 38. China Diabetic Macular Edema Treatment Market Share by Type (2019-2030) Figure 39. China Diabetic Macular Edema Treatment Market Share by Application (2019-2030) Figure 40. Asia Diabetic Macular Edema Treatment Market Size YoY (2019-2030) & (US$ Million) Figure 41. Asia Diabetic Macular Edema Treatment Market Share by Type (2019-2030) Figure 42. Asia Diabetic Macular Edema Treatment Market Share by Application (2019-2030) Figure 43. Asia Diabetic Macular Edema Treatment Market Share by Region (2019-2030) Figure 44. Japan Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 45. South Korea Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 46. China Taiwan Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 47. Southeast Asia Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 48. India Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 49. Australia Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 50. Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Size YoY (2019-2030) & (US$ Million) Figure 51. Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Share by Type (2019-2030) Figure 52. Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Share by Application (2019-2030) Figure 53. Middle East, Africa, and Latin America Diabetic Macular Edema Treatment Market Share by Country (2019-2030) Figure 54. Brazil Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 55. Mexico Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 56. Turkey Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 57. Saudi Arabia Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 58. Israel Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 59. GCC Countries Diabetic Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 60. Genentech Revenue Growth Rate in Diabetic Macular Edema Treatment Business (2019-2024) Figure 61. Novartis Revenue Growth Rate in Diabetic Macular Edema Treatment Business (2019-2024) Figure 62. GlaxoSmithKline Revenue Growth Rate in Diabetic Macular Edema Treatment Business (2019-2024) Figure 63. Eyetech Pharmaceuticals Revenue Growth Rate in Diabetic Macular Edema Treatment Business (2019-2024) Figure 64. Alimera Sciences Revenue Growth Rate in Diabetic Macular Edema Treatment Business (2019-2024) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed
01. サンプル提供
ご購入前にサンプル(英語、日本語)が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込(納品後、ご請求書送付)。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合:
レポート選択
見積もり依頼
メールでのご注文
入手(英語版は2〜4営業日、日本語版は8〜10営業日)
決済(後払い)
クレジットカード決済の場合:
レポート選択
ウェブサイトでのご注文
決済
入手(英語版は2〜4営業日、日本語版は8〜10営業日)